Significant factors limit MDMA’s ability to be used in the treatment of post-traumatic stress disorder. Significant factors limit MDMA’s ability to be used in the treatment of PTSD, including legal status and substantial study limitations.
While some studies suggest that 3,4-methylenedioxymethamphetamine (MDMA)-assisted therapy can reduce symptoms of post-traumatic stress disorder (PTSD) in patients, significant factors limit its use in treating this population, according to study results presented at the American Psychiatric Nurses Association 38th annual conference, held in Louisville, Kentucky from October 9-12, 2024.
Guideline-recommended therapies for PTSD include psychotherapy and some medications, such as selective serotonin reuptake inhibitors (SSRIs) and selective serotonin and norepinephrine reuptake inhibitors (SNRIs). While traditional therapies may work for many patients, some remain unresponsive and require other treatment options. The literature suggests that alternative medications, including MDMA-assisted therapy , could help address PTSD symptoms due to its neurobiological and psychological mechanisms. Results of the Study
Because of the limited efficacy of conventional PTSD treatments, the study author conducted research to understand the mechanism and implications of MDMA as a potential therapy option for patients with PTSD. The study authors found evidence that shows MDMA-assisted psychotherapy can significantly reduce PTSD symptom severity compared with traditional treatments, such as paroxetine and sertraline.
The mechanism of MDMA’s therapeutic effect is because of its ability to decrease fear response to traumatic events. Another symptom of PTSD that improves with the use of MDMA-assisted therapy is a decrease in flashbacks. The author noted that MDMA-assisted therapy can also increase introspection and improve interpersonal trust and therapeutic alliances between patients, therapists, and other health care providers.
Preliminary results suggest MDMA-assisted therapy could also reduce alcohol consumption in patients with alcohol use disorder, pointing to its potential utility in treating comorbid conditions alongside PTSD. Limitations and Ethical Considerations
Other considerations for MDMA-assisted therapy included the classification of the medication as a Schedule I drug under the Controlled Substances Act , which limits its use in many health care settings. The study author emphasized the importance of learning to navigate the legal and ethical pathways for the use of MDMA-assisted therapy as a health […]
Get Creative with Cannabis: The Ultimate Guide to Painting and Pottery Workshops
Creative with Cannabis Cannabis and creativity go hand in hand—especially
